Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient Care

Pharmacy Times, December 2014 Heart Health, Volume 80, Issue 12

This activity has been supported through an independent educational grant from Teva Pharmaceuticals.

Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist’s Role in Advancing Patient Care

Mitra Habibi, PharmD

Clinical Assistant Professor

University of Illinois at Chicago

Clinical Pharmacist, Neurology

University of Illinois Hospital &

Health Sciences System

Chicago, Illinois

Educational Objectives

After participating in this activity, participants should be able to:

  • Recall the incidence, etiology, and pathophysiology of multiple sclerosis (MS) and strategies to help patients understand the importance of treating early to slow disease progression.
  • Discuss the available disease-modifying therapies and explain strategies to improve patient adherence to these agents, including patient assistance programs.
  • Provide patient counseling information regarding medications available to treat exacerbations and manage symptoms of MS.
  • Evaluate emerging therapies for the treatment of MS.

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

December 8, 2014

Expiration date:

December 8, 2016

Estimated time to complete activity:

2.0 hours

Fee:

This lesson is offered free at www.pharmacytimes.org.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-110-H01-P. The activity is available for CE credit through December 8, 2016.